Literature DB >> 17699457

Kidney function, electrocardiographic findings, and cardiovascular events among older adults.

Bryan Kestenbaum1, Kyle D Rudser, Michael G Shlipak, Linda F Fried, Anne B Newman, Ronit Katz, Mark J Sarnak, Stephen Seliger, Catherine Stehman-Breen, Ronald Prineas, David S Siscovick.   

Abstract

Chronic kidney disease (CKD) is associated with cardiovascular (CV) disease and mortality. It is not known whether cardiac rhythm disturbances are more prevalent among individuals with CKD or whether resting electrocardiogram findings predict future CV events in the CKD setting. Data were obtained from the Cardiovascular Health Study, a community-based study of adults aged >/=65 yr. After exclusions for prevalent heart disease, atrial fibrillation, implantable pacemaker, or antiarrhythmic medication use, 3238 participants were analyzed. CKD was defined by an estimated GFR <60 ml/min per 1.73 m(2). Outcomes were adjudicated incident heart failure (HF), incident coronary heart disease (CHD), and mortality. Participants with CKD had longer PR and corrected QT intervals compared with those without CKD; however, differences in electrocardiographic markers were explained by traditional CV risk factors and CV medication use. After adjustment for known risk factors, each 10-ms increase in the QRS interval was associated with a 15% greater risk for incident HF (95% confidence interval [CI] 1.04 to 1.27), a 13% greater risk for CHD (95% CI 1.04 to 1.24), and a 17% greater risk for mortality (95% CI 1.09, 1.25) among CKD participants. Each 5% increase in QTI was associated with a 42% (95% CI 1.23 to 1.65), 22% (95% CI 1.07 to 1.40), and 10% (95% CI 0.98 to 1.22) greater risk for HF, CHD, and mortality, respectively. Associations seemed stronger for participants with CKD; however, no significant interactions were detected. Resting electrocardiographic abnormalities are common in CKD and independently predict future clinical CV events in this setting.

Entities:  

Mesh:

Year:  2007        PMID: 17699457     DOI: 10.2215/CJN.04231206

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  18 in total

Review 1.  The potential of electrocardiography for cardiac risk prediction in chronic and end-stage kidney disease.

Authors:  Sofia Skampardoni; Dimitrios Poulikakos; Marek Malik; Darren Green; Philip A Kalra
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

2.  Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD.

Authors:  Rajat Deo; Haochang Shou; Elsayed Z Soliman; Wei Yang; Joshua M Arkin; Xiaoming Zhang; Raymond R Townsend; Alan S Go; Michael G Shlipak; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2015-07-09       Impact factor: 10.121

3.  Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.

Authors:  Soren Snitker; Rebecca M Doerfler; Elsayed Z Soliman; Rajat Deo; Wendy L St Peter; Susan Kramlik; Michael J Fischer; Sankar Navaneethan; Patrice Delafontaine; Bernard G Jaar; Akinlolu Ojo; Gail K Makos; Anne Slaven; Matthew R Weir; Min Zhan; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-09       Impact factor: 8.237

4.  Electrocardiogram abnormalities and heart rate variability in predicting mortality and cardiovascular events among hemodialyzed patients.

Authors:  Silvia Badarau; Dimitrie Siriopol; Daniela Drugus; Raluca Dumea; Simona Hogas; Mihaela Blaj; Luminita Voroneanu; Angelica Gramaticu; Antoniu Petris; Alexandru Burlacu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

5.  Incidence and Risk Factors for Permanent Pacemaker Implantation Following Mitral or Aortic Valve Surgery.

Authors:  Gil Moskowitz; Kimberly N Hong; Gennaro Giustino; A Marc Gillinov; Gorav Ailawadi; Joseph J DeRose; Alexander Iribarne; Alan J Moskowitz; Annetine C Gelijns; Natalia N Egorova
Journal:  J Am Coll Cardiol       Date:  2019-11-26       Impact factor: 24.094

6.  eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Authors:  Nisha Bansal; Leila R Zelnick; Alvaro Alonso; Emelia J Benjamin; Ian H de Boer; Rajat Deo; Ronit Katz; Bryan Kestenbaum; Jehu Mathew; Cassianne Robinson-Cohen; Mark J Sarnak; Michael G Shlipak; Nona Sotoodehnia; Bessie Young; Susan R Heckbert
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-10       Impact factor: 8.237

Review 7.  QT interval in CKD and haemodialysis patients.

Authors:  Biagio Di Iorio; Antonio Bellasi
Journal:  Clin Kidney J       Date:  2013-01-17

8.  Electrocardiogram findings at the initiation of hemodialysis and types of subsequent cardiovascular events.

Authors:  Satoshi Yamaguchi; Takayuki Hamano; Tatsufumi Oka; Yohei Doi; Sachio Kajimoto; Seiichi Yasuda; Karin Shimada; Ayumi Matsumoto; Yusuke Sakaguchi; Kazunori Inoue; Isao Matsui; Akira Suzuki; Yoshitaka Isaka
Journal:  Hypertens Res       Date:  2021-01-04       Impact factor: 3.872

9.  Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.

Authors:  Alexander J Kula; Ronit Katz; Leila R Zelnick; Elsayed Soliman; Alan Go; Michael Shlipak; Rajat Deo; Bonnie Ky; Ian DeBoer; Amanda Anderson; Rob Christenson; Stephen L Seliger; Chris Defilippi; Harold I Feldman; Myles Wolf; John Kusek; Tariq Shafi; Jiang He; Nisha Bansal
Journal:  Nephrol Dial Transplant       Date:  2021-12-02       Impact factor: 5.992

10.  Mortality in patients on renal replacement therapy and permanent cardiac pacemakers.

Authors:  Gabriel Vanerio; Cristina García; Carlota González; Alejandro Ferreiro
Journal:  Int J Nephrol       Date:  2014-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.